The key m6A methylation regulator IGF2BP1 possesses potential prognostic value in papillary thyroid carcinoma
Abstract Papillary thyroid carcinoma (PTC) poses a risk of recurrence, and the efficacy of existing treatments is limited. Consequently, there is an urgent need to identify new prognostic markers and potential therapeutic targets. N6-methyladenosine (m6A) mRNA methylation is involved in tumorigenesi...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Portfolio
2026-03-01
|
| Serija: | Scientific Reports |
| Teme: | |
| Online pristup: | https://doi.org/10.1038/s41598-026-43501-z |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
